You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 19, November 19, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Pediatric/ Neonatal Critical Care
 •Pain
 •Pediatrics
 •Neonatology and Infant Care
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Prevention of Pain in Neonates

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The prevention of pain in neonates should be the goal of all caregivers, but the evidence for improved clinical outcomes with adequate pain control in newborns has been limited. The results of the NEOPAIN trial, the largest randomized controlled trial to date to evaluate benefits of pain control in critically ill neonates, indicated that morphine infusion in ventilated preterm infants controlled pain but had no beneficial effects on pulmonary outcomes and neurological morbidities.1-2 The use of open-label morphine doses was associated with significant adverse effects.1-2 Potential long-term benefits of pain control on neurodevelopmental outcomes for these infants have not yet been assessed. Summary proceedings from the Neonatal Pain Control Group again identified significant gaps in knowledge and raised concerns about possible adverse effects of analgesic exposure on long-term global developmental outcomes.3

In the absence of a clear risk-benefit analysis favoring use of pharmacologic analgesics, it is concerning . . . [Full Text of this Article]

Praveen Kumar, MBBS, DCH, MD
p-kumar@northwestern.edu
Department of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Epidemiology and Treatment of Painful Procedures in Neonates in Intensive Care Units
Ricardo Carbajal, André Rousset, Claude Danan, Sarah Coquery, Paul Nolent, Sarah Ducrocq, Carole Saizou, Alexandre Lapillonne, Michèle Granier, Philippe Durand, Richard Lenclen, Anne Coursol, Philippe Hubert, Laure de Saint Blanquat, Pierre-Yves Boëlle, Daniel Annequin, Patricia Cimerman, K. J. S. Anand, and Gérard Bréart
JAMA. 2008;300(1):60-70.
ABSTRACT | FULL TEXT  

RELATED LETTER

Prevention of Pain in Neonates—Reply
Ricardo Carbajal and K. J. S. Anand
JAMA. 2008;300(19):2248-2249.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.